-
Bajaj Finance
1,151.20 1,151.20(%) -
Torrent Pharma.
5,139.30 5,139.30(%) -
Netweb Technol.
4,597.95 5,241.65(%) -
TVS Motor Co.
4,320.00 4,320.00(%) -
Rossell Techsys
979.95 1,111.00(%) -
Indo-MIM
815.90 815.90(%) -
Kaynes Tech
3,860.55 7,705.00(%) -
Hero Motocorp
5,397.80 6,390.00(%) -
63 Moons Tech.
949.65 1,029.35(%) -
Adani Ports
1,707.00 1,891.80(%) -
Shadowfax Technologies
253.35 253.35(%) -
Kalyan Jewellers
610.15 327.15(%) -
M & M
3,456.00 3,840.00(%) -
Tata Motors
440.40 508.95(%) -
HFCL
194.30 229.40(%) -
Hyundai Motor I
2,208.90 2,889.65(%) -
Swiggy
280.00 235.85(%) -
TBO Tek
1,565.80 1,764.00(%) -
Reliance Industries
1,309.30 1,611.20(%) -
Eicher Motors
7,795.00 5,390.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Divis Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs
- Indian Private
- BSE Code : 21188.0
- ISIN : INE361B01024
-
Today’s Low
7,870.50 -
Today’s High
8,090.00
-
Open
7,873.00 -
Perv Close
7,835.00 -
52W Low
5,636.50 -
52W High
8,090.00
Key Indicators
-
P/E(TTM)
80.33
-
Mar.Cap (₹Cr.)
213,861.49
-
Div & Yield %
0.37
-
Book Value(₹)
629.49
-
Debt-Equity Ratio
2.82
-
AGM Date
31-Jul-2026
-
EPS
100.29
-
P/E Ratio
80.33
Financials Ratios
-
Debt-Equity Ratio
0.00
-
Mar.Cap (₹Cr.)
213,861.49
-
RONW (%)
12.15
-
ROCE (%)
16.41
Score Board
-
Equity (₹ in Cr.)
53.09
-
BV (₹)
629.50
-
Sales( ₹ in Cr.)
10,388.00
-
NP (in Cr.)
2,662.28
-
NP Var(%)
21.0
-
Div%
1500.0
-
CPS (₹)
117.70
-
EPS (₹)
100.30
-
Traded Value (₹ in Lakhs)
213,878.74
-
52 Week High
8,090.00
-
52 Week Low
5,636.50
-
Price BSE
8057.0
-
Price NSE
8,056.00
-
Market Capital( in Cr.)
213,878.74
-
P/C Ratio
68.50
-
P/E Ratio
80.30
-
Price Vs.BV
100.30
-
31-Jul-2026( 01:00)
Hot Pursuit - Divis... - <p>Divis Laboratories Ltd rose...
-
31-Jul-2026( 10:27)
Corporate News - Divi'... - Divi's Laboratories Limited in...
-
29-Jul-2026( 01:05)
Hot Pursuit - Divis... - <p>Divis Laboratories Ltd gain...
-
20-Jul-2026( 09:16)
Corporate News - Divis... - Divis Laboratories will hold a...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 10,388.00 | 9,198.00 | 7,665.00 | 7,625.00 | 8,879.82 | 6,798.61 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 10,388.00 | 9,198.00 | 7,665.00 | 7,625.00 | 8,879.82 | 6,798.61 |
| Other Income | 506.00 | 352.00 | 337.00 | 349.00 | 111.26 | 62.53 |
| Stock Adjustments | 244.00 | 83.00 | 127.00 | -50.00 | 449.99 | 100.00 |
| Total Income | 11,138.00 | 9,633.00 | 8,129.00 | 7,924.00 | 9,441.07 | 6,961.14 |
| EXPENDITURE : | ||||||
| Raw Materials | 4,339.00 | 3,827.00 | 3,270.00 | 3,035.00 | 3,499.18 | 2,416.47 |
| Power and Fuel Cost | 530.00 | 465.00 | 477.00 | 496.00 | 390.05 | 319.15 |
| Employee Cost | 1,400.00 | 1,210.00 | 1,067.00 | 953.00 | 926.55 | 808.68 |
| Other Manufacturing Expenses | 325.00 | 276.00 | 299.00 | 285.00 | 255.38 | 202.29 |
| Selling and Administration Expenses | 509.00 | 460.00 | 367.00 | 402.00 | 340.16 | 292.53 |
| Miscellaneous Expenses | 114.00 | 63.00 | 137.00 | 55.00 | 40.95 | 37.69 |
| Employee Benefit Expenses | 1,400.00 | 1,210.00 | 1,067.00 | 953.00 | 926.55 | 808.68 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 7,217.00 | 6,301.00 | 5,617.00 | 5,226.00 | 5,452.27 | 4,076.81 |
| Operating Profit | 3,921.00 | 3,332.00 | 2,512.00 | 2,698.00 | 3,988.80 | 2,884.33 |
| Interest | 24.00 | 2.00 | 4.00 | 2.00 | 1.73 | 1.81 |
| Gross Profit | 3,897.00 | 3,330.00 | 2,508.00 | 2,696.00 | 3,987.07 | 2,882.52 |
| Depreciation | 461.00 | 401.00 | 376.00 | 342.00 | 310.55 | 254.65 |
| Profit Before Tax | 3,436.00 | 2,929.00 | 2,132.00 | 2,354.00 | 3,676.52 | 2,627.87 |
| Current Tax | 869.00 | 793.00 | 511.00 | 438.00 | 637.20 | 609.05 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -40.00 | -73.00 | 45.00 | 108.00 | 90.78 | 64.10 |
| Reported Net Profit | 2,607.00 | 2,209.00 | 1,576.00 | 1,808.00 | 2,948.54 | 1,954.72 |
| Extraordinary Items | -55.28 | 0.00 | 0.74 | 3.07 | -1.65 | -2.45 |
| Adjusted Net Profit | 2,662.28 | 2,209.00 | 1,575.26 | 1,804.93 | 2,950.19 | 1,957.17 |
| Adjustment below Net Profit | 6.00 | -2.00 | -1.00 | 2.00 | 2.18 | 0.16 |
| P & L Balance brought forward | 13,357.00 | 11,725.00 | 10,922.00 | 9,967.00 | 7,588.31 | 5,814.44 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 604.00 | 575.00 | 772.00 | 855.00 | 571.50 | 181.01 |
| P & L Balance carried down | 15,366.00 | 13,357.00 | 11,725.00 | 10,922.00 | 9,967.53 | 7,588.31 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 1,500.00 | 1,500.00 | 1,500.00 | 1,500.00 | 1,500.00 | 1,000.00 |
| Dividend Per Share(Rs) | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 20.00 |
| Earnings Per Share-Unit Curr | 98.38 | 83.36 | 59.47 | 68.23 | 111.08 | 73.64 |
| Earnings Per Share(Adj)-Unit Curr | 98.38 | 83.36 | 59.47 | 68.23 | 111.08 | 73.64 |
| Book Value | 630.60 | 562.08 | 508.83 | 479.43 | 440.44 | 349.28 |
| Book Value(Adj)-Unit Curr | 630.60 | 562.08 | 508.83 | 479.43 | 440.44 | 349.28 |
